Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market Snapshot
Chapter 4. Global Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By ADC Linker Technologies Types Estimates & Trend Analysis
5.1. By ADC Linker Technologies Types & Market Share, 2022 & 2030
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By ADC Linker Technologies Types:
5.2.1. Non-cleavable Linkers
5.2.2. Cleavable Linkers
Chapter 6. Market Segmentation 2: By ADC Linker Technologies Type Estimates & Trend Analysis
6.1. By ADC Linker Technologies Type & Market Share, 2022 & 2030
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By ADC Linker Technologies Type:
6.2.1. Chemical Conjugation
6.2.2. Enzymatic Conjugation
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2022& 2030
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Application:
7.2.1. Leukemia
7.2.2. Lymphoma
7.2.3. Breast Cancer
7.2.4. Ovarian Cancer
7.2.5. Lung Cancer
7.2.6. Brain Tumor
Chapter 8. Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts By ADC Linker Technologies Types, 2022 - 2030
8.1.2. North America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts By ADC Linker Technologies Type, 2022 - 2030
8.1.3. North America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts by Application, 2022 - 2030
8.1.4. North America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030
8.2. Europe
8.2.1. Europe Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Types, 2022 - 2030
8.2.2. Europe Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Type, 2022 - 2030
8.2.3. Europe Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts by Application, 2022 - 2030
8.2.4. Europe Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) by country, 2022 - 2030
8.3. Asia Pacific
8.3.1. Asia Pacific Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Types, 2022 - 2030
8.3.2. Asia Pacific Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Type, 2022 - 2030
8.3.3. Asia Pacific Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts by Application, 2022 - 2030
8.3.4. Asia Pacific Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) by country, 2022 - 2030
8.4. Latin America
8.4.1. Latin America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Types, (US$ Million)
8.4.2. Latin America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Type, (US$ Million)
8.4.3. Latin America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts by Application, 2022 - 2030
8.4.4. Latin America Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
8.5. Middle East & Africa
8.5.1. Middle East & Africa Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Types, (US$ Million)
8.5.2. Middle East & Africa Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) By ADC Linker Technologies Type, (US$ Million)
8.5.3. Middle East & Africa Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) estimates and forecasts by Application, 2022 - 2030
8.5.4. Middle East & Africa Antibody Drug Conjugates (Adcs) – Linker And Conjugation Technologies Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Seattle Genetics, Inc.
9.2.2. ImmunoGen
9.2.3. Ambrx
9.2.4. Catalent Biologics
9.2.5. Immunomedics
9.2.6. Mersana Therapeutics
9.2.7. Sutro Biopharma
9.2.8. Iksuda Therapeutics
9.2.9. LegoChem Biosciences
9.2.10. LinXis
9.2.11. ADC therapeutics
9.2.12. NBE Therapeutics
9.2.13. Takeda Pharmaceutical Company Limited
9.2.14. Pfizer Inc
9.2.15. Hoffmann-La Roche Ltd
9.2.16. AbbVie Inc
9.2.17. AstraZeneca plc
9.2.18. Oxford BioTherapeutics Ltd.
9.2.19. Novartis AG
9.2.20. Angiex
9.2.21. Levena Biopharma
9.2.22. Synthon
9.2.23. Bayer Healthcare Pharmaceuticals
9.2.24. Zymeworks
9.2.25. Spirogen
9.2.26. Cerbios-Pharma
9.2.27. Other Prominent Players